Finance

Lists
NRX:CVE
Nurexone Biologic Inc
CAD 0,59
-1,67%
(-0,010) 1D
19 Okt., 13:21:42 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NRX...
Open
CAD 0,61
High
CAD 0,61
Low
CAD 0,59
Mkt. cap
56,87 m
Avg. vol.
17,67 k
Volume
5,00 k
52-wk high
CAD 0,89
52-wk low
CAD 0,44
EPS
-CAD 0,10
Beta
0,23
Shares outstanding
96,40 m
No. of employees
9
Open
CAD 0,61
High
CAD 0,61
Low
CAD 0,59
Mkt. cap
56,87 m
Avg. vol.
17,67 k
Volume
5,00 k
52-wk high
CAD 0,89
52-wk low
CAD 0,44
EPS
-CAD 0,10
Beta
0,23
Shares outstanding
96,40 m
No. of employees
9
News stories
From web sources and news partners
About Nurexone Biologic Inc
CEO-
Employees9
Founded2011
Headquarters-
Sector-
Websitenurexone.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
703,00 k
619,00 k
630,00 k
748,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
763,00 k
716,00 k
1,13 m
927,00 k
Operating expense
1,47 m
1,34 m
1,76 m
1,68 m
Total operating expenses
1,47 m
1,34 m
1,76 m
1,68 m
Operating income
-1,47 m
-1,34 m
-1,76 m
-1,68 m
Other non operating income
-20,00 k
5,00 k
-6,00 k
-6,00 k
EBT including unusual items
-1,46 m
-1,40 m
-1,77 m
-1,68 m
EBT excluding unusual items
-1,46 m
-1,40 m
-1,77 m
-1,68 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,46 m
-1,40 m
-1,77 m
-1,68 m
Net profit margin
-
-
-
-
Earnings per share
-0,02
-0,02
-0,02
-0,02
Interest and investment income
21,00 k
27,00 k
6,00 k
13,00 k
Interest expense
-
-43,00 k
-9,00 k
-15,00 k
Net interest expenses
21,00 k
-16,00 k
-3,00 k
-2,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,42 m
-1,31 m
-1,70 m
-1,62 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme